Engineered T-cell receptor (TCR) therapies hold a promising future in the realm of oncology, particularly for solid tumors—long considered a formidable adversary due to their complex microenvironment. In a strategic move, AmplifyBio and Xcell Biosciences have joined forces with a shared vision of b
In an industry where time-to-market is critical, a strategic collaboration between AGC Biologics, a global leader in biopharmaceutical development, and BioConnection, an aseptic filling expert, may be the key to unlocking faster pathways from laboratory to patient. As biotechnology firms grapple
The biotechnology sector could be on the brink of a substantial change as legislative gears turn with the possibility of the BIOSECURE Act being widened to encompass drug developers. This pivot towards inclusive scrutiny, primarily targeting relationships with Chinese biopharma entities, sparks a
The rapid pace and intricate processes of modern drug development call for efficiency, precision, and scalability—goals that are increasingly being met through the adoption of laboratory automation technologies. From target identification to quality control, these systems enhance biopharma research
Cauliflower, the nutrient-dense vegetable that graces dinner tables around the world, has a fascinating evolutionary history that has eluded scientists until recently. Though it has long been believed that cauliflower resulted from selective breeding by Mediterranean farmers over two thousand years
The field of oncology is undergoing a transformative shift with the advent of personalized medicine. This approach tailors treatments to individual patient profiles, greatly enhancing the efficacy and reducing the side effects of cancer therapies. Such customization is possible due to advancements
